µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : Á¦Ç° À¯Çü, ±â¼ú, µ¿¹° À¯Çü, ÀûÀÀÁõ Áúȯ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Veterinary Molecular Diagnostic Market by Product (Instruments & Software, Kits & Reagent, Services), Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction), Animal Type, Disease Indication, End User - Global Forecast 2025-2030
»óǰÄÚµå : 1599255
¸®¼­Ä¡»ç : 360iResearch Private Limited
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 191 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,939 £Ü 5,699,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 4,249 £Ü 6,147,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 5,759 £Ü 8,332,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ Áö¿ª »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 6,969 £Ü 10,083,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº 2023³â 5¾ï 7,974¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 6¾ï 3,240¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.17% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 10¾ï 7,185¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº PCR, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)°ú °°Àº ÷´Ü Áø´Ü ±â¼ú¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, º´¿øÃ¼, À¯ÀüÀû Áúº´ ¹× ±âŸ ºÐÀÚ ¼öÁØ¿¡¼­ µ¿¹°ÀÇ °Ç°­ ¹®Á¦¸¦ ³ôÀº Á¤È®µµ·Î ½Äº°ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áø´ÜÀÇ Çʿ伺Àº Àμö°øÅëÀü¿°º´ Áõ°¡, µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ½Äǰ ¾ÈÀü °­È­ÀÇ Çʿ伺¿¡¼­ ºñ·ÔµË´Ï´Ù. ¿ëµµ´Â ¹Ý·Áµ¿¹°, °¡Ãà, ¿¬±¸¿ë °¡ÃàÀÇ °ü¸®¿¡ °ÉÃÄ ¼öÀÇ»ç, Áø´Ü ½ÇÇè½Ç, ¿¬±¸ ±â°ü¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ±â¼ú ¹ßÀü, ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, ¼öÀÇÇÐ ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ, µ¿¹° Áúº´ ¹ß»ý·ü Áõ°¡ µîÀÔ´Ï´Ù. ƯÈ÷, AI¿Í ¸Ó½Å·¯´×ÀÇ Áø´Ü ºÐ¾ß ÅëÇÕ°ú ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ °áÇյǾî Å« ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ, °Ë»ç ¹Î°¨µµ Çâ»ó, ½Å±Ô ¹× ½ÅÈï º´¿øÃ¼¸¦ Æ÷ÇÔÇÑ °Ë»ç Á¦°ø È®´ë µîÀ» ÅëÇØ ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ºÐÀÚÁø´ÜÀÇ ³ôÀº ºñ¿ë, ½ÅÈï±¹ Áö¿ªÀÇ Á¦ÇÑµÈ ¼öÀÇÇÐ ÀÎÇÁ¶ó, ±ÔÁ¦ À庮 µî ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ´Â ¿©·¯ °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â ºñ¿ë È¿À²ÀûÀÎ ±â¼ú, ÈÞ´ë¿ë Áø´Ü ±â±â, Á¾ÇÕÀûÀÎ À¯Àüü °Ë»ç¿¡ ÃÊÁ¡À» ¸ÂÃá ±â¼ú Çõ½ÅÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. ¿©·¯ º´¿øÃ¼¸¦ µ¿½Ã¿¡ °Ë»çÇÒ ¼ö ÀÖ´Â ¸ÖƼÇ÷º½º ºÐ¼®¿¡ ´ëÇÑ ¿¬±¸µµ ÁøÇàµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇÏ°í ±âÁ¸ ±â¾÷°ú ½Å»ý ±â¾÷ÀÌ È¥ÀçµÇ¾î ´ÜÆíÈ­µÇ¾î Àֱ⠶§¹®¿¡ Áö¸®Àû ÀÔÁö¿Í Á¦Ç° Á¦°øÀ» È®´ëÇϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ¿¡ ÁýÁßÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý µ¿¹° Áø´Ü µ¥ÀÌÅÍ ºÐ¼®ÀÇ Çõ½ÅÀº °³ÀÎÈ­µÈ µ¿¹° Áø·á ¼­ºñ½º¸¦ °­È­ÇÒ °ÍÀÔ´Ï´Ù. ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼öÀÇ»ç ±³À° ¹× ÈÆ·Ã¿¡ Àü·«ÀûÀ¸·Î ÁýÁßÇÏ´Â °ÍÀº äÅÃÀ» À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¼ºÀåÀ» ´Þ¼ºÇϱâ À§Çؼ­´Â °¡°Ý Ã¥Á¤ ¹®Á¦¸¦ ÇØ°áÇϰí, ÀÎÇÁ¶ó¸¦ È®ÀåÇϰí, ¹Ì°³Ã´ ½ÃÀå¿¡¼­ÀÇ Áø´Ü ¼­ºñ½º Á¢±Ù¼ºÀ» °³¼±ÇÏ¿© ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÇ º¸±Þ°ú ¿µÇâ·ÂÀ» È®º¸ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 5¾ï 7,974¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 6¾ï 3,240¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 10¾ï 7,185¸¸ ´Þ·¯
CAGR(%) 9.17%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Porter's Five Forces : µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå °æÀï »óȲ ÆÄ¾Ç

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : Á¦Ç°º°

Á¦7Àå µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : ±â¼úº°

Á¦8Àå µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : µ¿¹° Á¾·ùº°

Á¦9Àå µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : Áúȯ ÀûÀÀÁõº°

Á¦10Àå µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå

Á¦14Àå °æÀï »óȲ

±â¾÷ ¸®½ºÆ®

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Veterinary Molecular Diagnostic Market was valued at USD 579.74 million in 2023, expected to reach USD 632.40 million in 2024, and is projected to grow at a CAGR of 9.17%, to USD 1,071.85 million by 2030.

The veterinary molecular diagnostic market focuses on advanced diagnostic techniques like PCR, microarrays, and next-generation sequencing (NGS) to identify pathogens, genetic disorders, and other molecular-level health issues in animals with high accuracy. The necessity for such diagnostics arises from the increased prevalence of zoonotic diseases, growing awareness toward animal health, and the need for enhanced food safety. Applications span across companion animals, livestock, and research livestock management, serving veterinarians, diagnostic labs, and research institutes. Key factors driving growth include technological advancements, increased pet ownership, investments in veterinary healthcare, and the rising incidence of animal diseases. Notably, the growing integration of AI and machine learning in diagnostics, combined with the demand for minimally invasive procedures, creates significant opportunities. Companies can capitalize on these opportunities by investing in automation, enhancing test sensitivity, and broadening their test offerings to include novel and emerging pathogens. However, the market faces challenges such as high costs of molecular diagnostics, limited veterinary infrastructure in developing regions, and regulatory hurdles, which can impede growth. The field can benefit from innovations focused on cost-effective technologies, portable diagnostic devices, and comprehensive genomic testing. Research might explore multiplex assays capable of simultaneous testing for multiple pathogens. The market is competitive and fragmented with a mix of established firms and startups, necessitating a focus on strategic partnerships and collaborations to expand geographical presence and product offerings. Innovation in cloud-based data analytics for veterinary diagnostics will enhance personalized animal care services. Strategic focus on education and training for veterinarians on molecular diagnostics is crucial for adoption. Achieving growth requires addressing pricing issues, scaling up infrastructure, and increasing accessibility to diagnostic services in untapped markets, ensuring a wider reach and impact of these innovative diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 579.74 million
Estimated Year [2024] USD 632.40 million
Forecast Year [2030] USD 1,071.85 million
CAGR (%) 9.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Molecular Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Molecular Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Molecular Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Molecular Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Molecular Diagnostic Market

A detailed market share analysis in the Veterinary Molecular Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Molecular Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Molecular Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Molecular Diagnostic Market

A strategic analysis of the Veterinary Molecular Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Molecular Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Biochek BV, Biomedica Medizinprodukte GmbH, BioMerieux SA, Bioneer Corp, HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., Novacyt Group, Quality Vet Lab, Randox Laboratories, Ltd., Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Molecular Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Veterinary Molecular Diagnostic Market, by Product

7. Veterinary Molecular Diagnostic Market, by Technology

8. Veterinary Molecular Diagnostic Market, by Animal Type

9. Veterinary Molecular Diagnostic Market, by Disease Indication

10. Veterinary Molecular Diagnostic Market, by End User

11. Americas Veterinary Molecular Diagnostic Market

12. Asia-Pacific Veterinary Molecular Diagnostic Market

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

14. Competitive Landscape

Companies Mentioned

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â